SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-16-134057
Filing Date
2016-11-14
Accepted
2016-11-14 14:42:51
Documents
54
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q v452197_10q.htm 10-Q 353208
2 EXHIBIT 31.1 v452197_ex31-1.htm EX-31.1 10821
3 EXHIBIT 31.2 v452197_ex31-2.htm EX-31.2 10777
4 EXHIBIT 32.1 v452197_ex32-1.htm EX-32.1 4729
5 EXHIBIT 32.2 v452197_ex32-2.htm EX-32.2 4810
  Complete submission text file 0001144204-16-134057.txt   4190595

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT tlcc-20160930.xml EX-101.INS 858776
7 XBRL TAXONOMY EXTENSION SCHEMA tlcc-20160930.xsd EX-101.SCH 46096
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE tlcc-20160930_cal.xml EX-101.CAL 43725
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tlcc-20160930_def.xml EX-101.DEF 275913
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE tlcc-20160930_lab.xml EX-101.LAB 330093
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tlcc-20160930_pre.xml EX-101.PRE 310980
Mailing Address 632 BROADWAY SUITE 201 NEW YORK NY 10012
Business Address 632 BROADWAY SUITE 201 NEW YORK NY 10012 (212) 651-8500
TWINLAB CONSOLIDATED HOLDINGS, INC. (Filer) CIK: 0001590695 (see all company filings)

IRS No.: 463951742 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55181 | Film No.: 161993839
SIC: 2833 Medicinal Chemicals & Botanical Products